Wyeth Effexor XR Has Increased Risk Of Fatal Outcomes Versus SSRIs
New labeling for Wyeth's antidepressants Effexor XR (venlafaxine extended-release) and Effexor describes an increased risk of fatal outcomes associated with overdose, according to an Oct. 25 FDA MedWatch alert
You may also be interested in...
The ADC specialist could have a fourth cancer drug on the market this year and is preparing for its first commercial launch in Europe.
The virtual J.P. Morgan Healthcare meeting was missing the usual energy but still had substance.
US vaccination campaign will pick up speed now that access is broadening, leaders from Operation Warp Speed, Pfizer, Moderna, McKesson and CVS Health say at a J.P. Morgan panel discussion.